Moreover, CDKN2A promoter methylation has been associated with a 6.58-fold increase of breast cancer risk [44] and occurs frequently in mammary cells obtained from women with greater chances of developing breast cancer [45, 46]. This evidence concerns the gene CDKN2A and breast cancer.